AdAlta

Webinars

Updates

Home

Why Invest

Announcements

Lora

Non-executive director, Iain Ross, has tendered his resignation effective 30 June 2025 due to the potential for conflicts of interest to emerge between AdAlta and another company he serves.

"We are grateful for Iain’s support and counsel during a particularly challenging period for AdAlta as the company changed focus from internal drug discovery to our “East to West” cellular immunotherapy strategy. His experience transforming businesses has been invaluable."

AdAlta does not intend to replace Mr Ross at this time.

Board Change

Summary